Our mission: The Center for Structural Genomics of Infectious Diseases is a consortium of laboratories using state-of-the-art structural biology methods to determine the 3-D structures of proteins from pathogens in the NIAID Category A-C priority lists and organisms causing emerging and re-emerging infectious diseases. We do this as a free service to the scientific community! Members of the scientific community are encouraged to submit their targets of interest to CSGID by using our online form: Submit/check your proposal now!
For more detailed information about our mission, please refer to the CSGID brochure (pdf) and the Overview.

Latest news:
The study of Listeria Monocytogenes ROK Repressor Structures, published in a recent Nature Microbiology paper has been featured on the NIAID website.

Targets: 9020
Targets requested by the community: 3128
Community Interest targets: 149
Targets with structures: 670
Structures: 1014 (X-ray: 1008, NMR: 6)
Structures complexed with ligands: 413
Solved proteins requested by community: 241 (394 structures)
Solved Community Interest targets: 52 (112 structures)
Publications: 134 (74 structural, 60 methodological/other)
Citations: 2006 (772 for structural, 1234 for methodological/other)
This website has been visited 58,006 times by 28,841 users since October 2013.
Community Collaborators:
CSGID is soliciting requests from the scientific community for protein structure determination: submission form

Target IDP01169     Latest NIAID structure of the month

Title: AtxA protein, a virulence regulator from Bacillus anthracis

Authors: J.Osipiuk,L.B.Horton,T.M.Koehler,W.F.Anderson,A.Joachimiak,Center For Structural Genomics Of Infectious Diseases (Csgid)

Target IDP95667    Latest community request

Title: Crystal structure of the competence damage-inducible protein A (ComA) from Klebsiella pneumoniae subsp. pneumoniae MGH 78578

Authors: D.Borek,Z.Wawrzak,S.Grimshaw,J.Sandoval,E.Evdokimova,A.Savchenko,W.F.Anderson,Center For Structural Genomics Of Infectious Diseases (Csgid)


This project has been funded in whole or in part with Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contracts No. HHSN272200700058C and HHSN272201200026C.